Evaxion announce 2026 financial calendar

Core Insights - Evaxion A/S is a clinical-stage TechBio company focused on developing AI-Immunology™ powered vaccines, with a financial calendar for 2026 announced [1][2] Financial Calendar - March 5, 2026: Business update and full year 2025 financial results [1] - April 16, 2026: Annual General Meeting [1] - May 7, 2026: Business update and first quarter 2026 financial results [1] - August 20, 2026: Business update and second quarter 2026 financial results [1] - November 19, 2026: Business update and third quarter 2026 financial results [1] Company Overview - Evaxion utilizes its proprietary AI platform, AI-Immunology™, to develop novel immunotherapies targeting cancer, bacterial diseases, and viral infections [2] - The company has a clinical-stage oncology pipeline of personalized vaccines and a preclinical pipeline for infectious diseases with high unmet medical needs [2] - Evaxion aims to transform patient care by providing innovative and targeted treatment options [2]